Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Feb;34(1):37-49.
doi: 10.1007/s00270-010-0012-y. Epub 2010 Nov 12.

Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?

Eleni Liapi  1 , Jean-Francois H Geschwind
Affiliations
Review

Transcatheter arterial chemoembolization for liver cancer: is it time to distinguish conventional from drug-eluting chemoembolization?

Eleni Liapi et al. Cardiovasc Intervent Radiol. 2011 Feb.

Abstract

Conventional transcatheter arterial chemoembolization and chemoembolization with drug-eluting beads are increasingly being performed interchangeably in many institutions throughout the world. As both therapies continue to being tested in many phase II and III studies and in combination with other therapies, especially targeted agents, for treatment of primary and metastatic liver cancer, it is imperative to review their current status and evaluate their impact on patient survival. This review critically assesses patient selection, indications, contraindications, techniques, materials, safety, and clinical outcomes of patients treated with conventional chemoembolization and chemoembolization with drug-eluting beads.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Jean-Francois Geschwind: Consultancies in the last 3 years: BIOCOMPATIBLES, INC., BOSTON SCIENTIFIC, MDS NORDION, BIOSPHERE MEDICAL. Grants received in the last 3 years: GENENTECH, INC., BIOSPHERE MEDICAL, CON-TEXTVISION, INC., BOSTON SCIENTIFIC. Patents received: 20100203110 Therapeutics for Cancer Using 3-Bromopyruvate and Other Selective Inhibitors of ATP Production 08-12-2010; 201001 37434 Methods and compositions for administration of 3-halopyruvate and related compounds for the treatment of cancer 06-03-2010. Eleni Liapi: Employment: FEDERAL, THROUGH THE NIH T32 GRANT 5T32EB006351-02(PI: DEAN. F. WONG).

References

    1. Roche A, Girish B, de Baere T, et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol. 2003;13:136. - PubMed
    1. Stuart K. Chemoembolization in the management of liver tumors. Oncologist. 2003;8:425–437. - PubMed
    1. Geschwind JFH. Chemoembolization for hepatocellular carcinoma: where does the truth lie? J Vasc Interv Radiol. 2002;13:991–994. - PubMed
    1. Aoki T, Imamura H, Hasegawa K, et al. Sequential pre-operative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg. 2004;139:766–774. - PubMed
    1. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan. Hepatology. 2000;32:1224–1229. - PubMed

Publication types

MeSH terms

Substances